β-hydroxybutyrate is a metabolic regulator of proteostasis in the aged and Alzheimer disease brain.

阅读:4
作者:Madhavan Sidharth S, Roa Diaz Stephanie, Peralta Sawyer, Nomura Mitsunori, King Christina D, Ceyhan Kaya E, Lin Anwen, Bhaumik Dipa, Foulger Anna C, Shah Samah, Blade Thanh, Gray Wyatt, Chamoli Manish, Eap Brenda, Panda Oishika, Diaz Diego, Garcia Thelma Y, Stubbs Brianna J, Ulrich Scott M, Lithgow Gordon J, Schilling Birgit, Verdin Eric, Chaudhuri Asish R, Newman John C
Loss of proteostasis is a hallmark of aging and Alzheimer disease (AD). We identify β-hydroxybutyrate (βHB), a ketone body, as a regulator of protein solubility. βHB primarily provides ATP substrate during periods of reduced glucose availability, and regulates other cellular processes through protein interactions. We demonstrate βHB-induced protein insolubility is not dependent on covalent protein modification, pH, or solute load, and is observable in mouse brain in vivo after delivery of a ketone ester. This mechanism is selective for pathological proteins such as amyloid-β, and exogenous βHB ameliorates pathology in nematode models of amyloid-β aggregation toxicity. We generate libraries of the βHB-induced protein insolublome using mass spectrometry proteomics, and identify common protein domains and upstream regulators. We show enrichment of neurodegeneration-related proteins among βHB targets and the clearance of these targets from mouse brain. These data indicate a metabolically regulated mechanism of proteostasis relevant to aging and AD.

特别声明

1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。

2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。

3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。

4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。